HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...

HALIFAX, Nova Scotia, May 12, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its regulatory strategy by receiving the CE mark for ...

The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately.

HALIFAX, NOVA SCOTIA / ACCESS Newswire / August 26, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody ...

Syphilis is a sexually transmitted disease caused by the bacterium Treponema Pallidum. It affects sexually active people of both genders. Syphilis manifests in various regions of the body, in many ...

This week, the Food and Drug Administration (FDA) cleared the way for putting the first at-home, over-the-counter test to detect syphilis antibodies in human blood. Test-kits for syphilis for the ...

HALIFAX, NS / ACCESSWIRE / August 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces it will conduct full clinical trials for its unique Multiplo ® Complete Syphilis (TP/nTP) Antibody Test ...

Medmira ( ($TSE:MIR) ) has shared an update. MedMira reported first-quarter fiscal 2026 results marked by Health Canada approval of its Reveal TP ...

Credit: NOWDiagnostics The First to Know Syphilis Test retails for $29.99 and is available online and at major retailers and pharmacies. Positive results indicate the presence of antibodies to ...

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MIR:CA) (MedMira) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ® ...